Beyond ERBB2 amplification: RNA and proteomic HER2 assessment for pan-tumor treatment stratification
Egebjerg, K.; Rohrberg, K. S.; Bagger, F. O.; Laenkholm, A.-V.; Talman, M.-L. M.; Nielsen, A. B.; Wang, J.; Chelebian, E.; Strauss, M. T.; Mund, A.; Zheng, X.; Garbyal, R. S.; Nedergaard, M. K.; Conlon, B. H.; Robinson, L.; Kringelbach, T.; Hoejgaard, M.; Schmidt, A. Y.; Larsen, M. F.; Alosi, D.; Kodahl, A. R.; Eefsen, R. L.; Ladekarl, M.; Soendergaard, L.; Jensen, L. H.; Lassen, U. N.; Mau-Soerensen, M.
Show abstract
HER2-directed therapies are expanding across solid tumors, but ERBB2 amplification incompletely captures HER2 expression and pan-tumor IHC lacks standardization. We developed ERBB2 mRNA, bulk HER2 protein and RNA-signature screening benchmarked against IHC/FISH. Screening identified HER2-enriched populations beyond amplification in a pan-tumor discovery cohort of 1,331 tumor biopsies and validated RNA-based screening in an external cohort of 3,898 tumor biopsies. All six objective responses among 51 treated patients in the discovery cohort occurred in tumors positive by ERBB2 mRNA and the combined RNA-signature. In the external dataset (n=102), ERBB2 mRNA positivity was associated with longer time on treatment (hazard ratio 0.42, 95% confidence interval 0.27-0.64) and overall survival (0.41, 0.25-0.65), with concordant associations for the combined RNA signature. Spatial proteomics comprising 2,721 tiles across 88 samples captured HER2 hetero-geneity and identified HER2-enriched profiles below bulk thresholds. These findings support prospective evaluation of RNA and proteomic screening for treatment selection.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Real-World Benchmarking and Validation of Foundation Model Transformers for Endometrial Cancer Subtyping from Histopathology 94%
- Multi-omics analysis of serial samples from metastatic TNBC patients on PARP inhibitor monotherapy provide insight into rational PARP inhibitor therapy combinations 94%
- Mass spectrometry-based proteomics delivers in-depth proteome profiling of FFPE lung cancer biopsies from single glass slides 93%
Similar papers in this journal
- Multiplexed RNA-FISH-guided Laser Capture Microdissection RNA Sequencing Improves Breast Cancer Molecular Subtyping, Prognostic Classification, and Predicts Response to Antibody Drug Conjugates 95%
- Angiogenic and Immune Predictors of Neoadjuvant Axitinib Response in Renal Cell Carcinoma with Venous Tumour Thrombus 93%
- Artificial intelligence-based histopathology image analysis identifies a novel subset of endometrial cancers with distinct genomic features and unfavourable outcome 93%
Similar papers in this journal
- Leveraging sequences missing from the human genome to diagnose cancer 92%
- Gravity-based microfiltration reveals unexpected prevalence of circulating tumor cell clusters in ovarian and colorectal cancer 91%
- Deep plasma proteomics identifies and validates an eight-protein biomarker panel that separate benign from malignant tumors in ovarian cancer 91%
Similar papers in this journal
- The Tumor Profiler Study: Integrated, multi-omic, functional tumor profiling for clinical decision support 93%
- Genomic and transcriptomic determinants of therapy resistance and immune landscape evolution during anti-EGFR treatment in colorectal cancer 93%
- Multi-omic landscape of human gliomas from diagnosis to treatment and recurrence 92%
Similar papers in this journal
- Tamoxifen Response at Single Cell Resolution in Estrogen Receptor-Positive Primary Human Breast Tumors 93%
- Clinical Validation of Digital PCR-based ctDNA detection for risk stratification in residual triple negative breast cancer: TRICIA trial results 92%
- Non-invasive multi-cancer detection using DNA hypomethylation of LINE-1 retrotransposons 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.